{"paper_id":"dc2ad3a3-9980-4297-b81a-7a67b8605635","body_text":"Abstract\nEndometriosis is a common disease in women during the reproductive ages. Estimates of the frequency of endometriosis range from 3% to 20% of the white female population and it is certainly the most prominent gynecological entity after uterine fibroids. Present therapeutic modalities for endometriosis include conservative surgery or ovarian suppression with hormones. The use of medical treatments is directed towards achieving ovarian suppression to avoid the steroidal stimulation of ectopic endometrial tissues.\nPreview\nUnable to display preview. Download preview PDF.\nSimilar content being viewed by others\nAuthor information\nAuthors and Affiliations\nEditor information\nEditors and Affiliations\nRights and permissions\nCopyright information\n© 1990 Springer Science+Business Media Dordrecht\nAbout this chapter\nCite this chapter\nConti, A. (1990). LHRH Agonist Treatment of Endometriosis. In: Vickery, B.H., Lunenfeld, B. (eds) GnRH Analogues in Cancer and Human Reproduction. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-2169-6_4\nDownload citation\nDOI: https://doi.org/10.1007/978-94-009-2169-6_4\nPublisher Name: Springer, Dordrecht\nPrint ISBN: 978-94-010-7474-2\nOnline ISBN: 978-94-009-2169-6\neBook Packages: Springer Book Archive\nKeywords\nThese keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.","source_license":"CC0","license_restricted":false}